GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
44.37 -0.42  -0.94% NYSE May 29, 8:00PM Delayed 2m USD

GlaxoSmithKline Cash from Investing (TTM):

9.530B for March 31, 2015

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Cash from Investing (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Investing (TTM) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2015 9.530B
Dec. 31, 2014 -1.776B
Sept. 30, 2014 1.674B
June 30, 2014 1.202B
March 31, 2014 729.75M
Dec. 31, 2013 819.61M
Sept. 30, 2013 -2.430B
June 30, 2013 -5.407B
March 31, 2013 -4.858B
Dec. 31, 2012 -4.169B
Sept. 30, 2012 -4.506B
June 30, 2012 -1.084B
March 31, 2012 -1.289B
Dec. 31, 2011 -179.51M
Sept. 30, 2011 -280.69M
June 30, 2011 -691.25M
March 31, 2011 -1.044B
Dec. 31, 2010 -2.885B
Sept. 30, 2010 -2.884B
June 30, 2010 -6.109B
March 31, 2010 -5.811B
Dec. 31, 2009 -6.263B
Sept. 30, 2009 -6.820B
June 30, 2009 -3.224B
March 31, 2009 -2.569B
   
Dec. 31, 2008 -2.106B
Sept. 30, 2008 -3.432B
June 30, 2008 -3.766B
March 31, 2008 -4.594B
Dec. 31, 2007 -6.027B
Sept. 30, 2007 -4.562B
June 30, 2007 -4.677B
March 31, 2007 -4.431B
Dec. 31, 2006 -2.800B
Sept. 30, 2006 -3.807B
June 30, 2006 -3.364B
March 31, 2006 -3.426B
Dec. 31, 2005 -3.017B
Sept. 30, 2005 -1.044B
June 30, 2005 -1.374B
March 31, 2005 -1.306B
Dec. 31, 2004 -1.685B
Sept. 30, 2004 -2.087B
June 30, 2004 -1.697B
March 31, 2004 -1.571B
Dec. 31, 2003 -1.533B
Sept. 30, 2003 -1.597B
June 30, 2003 -1.605B
March 31, 2003 -1.694B
Dec. 31, 2002 -1.711B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Advertisement

GSK Cash from Investing (TTM) Benchmarks

Companies
Merck & Co -3.172B
AstraZeneca -3.811B
Bristol-Myers Squibb -242.00M

GSK Cash from Investing (TTM) Range, Past 5 Years

Minimum -6.109B Jun 2010
Maximum 9.530B Mar 2015
Average -1.282B

GSK Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("GSK", "cash_investing_ttm")
  • Last 5 data points: =YCS("GSK", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.